doi: 10.1186/1479-0556-1-2.
DNA vaccines: improving expression of antigens
Affiliations
- PMID: 14606963
- PMCID: PMC244903
- DOI: 10.1186/1479-0556-1-2
Item in Clipboard
DNA vaccines: improving expression of antigens
Genet Vaccines Ther.
.
Abstract
DNA vaccination is a relatively recent development in vaccine methodology. It is now possible to undertake a rational step-by-step approach to DNA vaccine design. Strategies may include the incorporation of immunostimulatory sequences in the backbone of the plasmid, co-expression of stimulatory molecules, utilisation of localisation/secretory signals, and utilisation of the appropriate delivery system, for example. However, another important consideration is the utilisation of methods designed to optimise transgene expression. In this review we discuss the importance of regulatory elements, kozak sequences and codon optimisation in transgene expression.
Similar articles
-
Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.Vaccine. 2011 Oct 13;29(44):7624-30. doi: 10.1016/j.vaccine.2011.08.020. Epub 2011 Aug 19. Vaccine. 2011. PMID: 21856352
-
Improving DNA vaccine performance through vector design.Curr Gene Ther. 2014;14(3):170-89. doi: 10.2174/156652321403140819122538. Curr Gene Ther. 2014. PMID: 25142448 Review.
-
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.Pharmacol Ther. 2016 Sep;165:32-49. doi: 10.1016/j.pharmthera.2016.05.004. Epub 2016 May 24. Pharmacol Ther. 2016. PMID: 27235391 Review.
-
Vaccination with a piggyBac plasmid with transgene integration potential leads to sustained antigen expression and CD8(+) T cell responses.Vaccine. 2014 Mar 26;32(15):1670-7. doi: 10.1016/j.vaccine.2014.01.063. Epub 2014 Feb 7. Vaccine. 2014. PMID: 24513010 Free PMC article.
-
A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.Vaccine. 2021 Dec 3;39(49):7175-7181. doi: 10.1016/j.vaccine.2021.10.008. Epub 2021 Nov 10. Vaccine. 2021. PMID: 34774358
Cited by
-
DNA Vaccines: Their Formulations, Engineering and Delivery.Vaccines (Basel). 2024 Jan 11;12(1):71. doi: 10.3390/vaccines12010071. Vaccines (Basel). 2024. PMID: 38250884 Free PMC article. Review.
-
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation.Genet Vaccines Ther. 2004 Mar 23;2(1):2. doi: 10.1186/1479-0556-2-2. Genet Vaccines Ther. 2004. PMID: 15038826 Free PMC article.
-
EP3 receptor isoforms are differentially expressed in subpopulations of primate granulosa cells and couple to unique G-proteins.Reproduction. 2013 Oct 21;146(6):625-35. doi: 10.1530/REP-13-0274. Print 2013 Dec. Reproduction. 2013. PMID: 24062570 Free PMC article.
-
Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen.Blood. 2009 Jan 1;113(1):37-45. doi: 10.1182/blood-2008-01-136267. Epub 2008 Oct 1. Blood. 2009. PMID: 18832136 Free PMC article.
-
[Trends in vaccine development].Pharm Unserer Zeit. 2008;37(1):86-92. doi: 10.1002/pauz.200700246. Pharm Unserer Zeit. 2008. PMID: 18081053 Free PMC article. Review.
References
-
- Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465–1468. - PubMed
-
- Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Gen. 1992;1:363–369. - PubMed
-
- Bartlett RJ, Secore SL, Singer JT, Bodo M, Sharma K, Ricordi C. Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: comparison of human creatine kinase and CMV promoter expression levels in vivo. Cell Transplant. 1996;5:411–419. doi: 10.1016/0963-6897(95)02026-8. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
